Articles published in Metabolomics:Open Access have been cited by esteemed scholars and scientists all around the world.
Metabolomics:Open Access has got h-index 14, which means every article in Metabolomics:Open Access has got 14 average citations.
Following are the list of articles that have cited the articles published in Metabolomics:Open Access.
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
Year wise published articles |
20 | 30 | 24 | 7 | 9 |
Year wise citations received |
102 | 110 | 105 | 105 | 96 |
| Journal total citations count | 895 |
| Journal impact factor | 1.8 |
| Journal 5 years impact factor | 3.73 |
| Journal cite score | 2.25 |
| Journal h-index | 14 |
| Journal h-index since 2018 | 9 |
Kaur, Gaganpreet, Saurabh Gupta, Gagandeep Kaur, Manju Verma, and Pawandeep Kaur. "Bioinformatics: An Important Tool in Oncology." Biomedical Data Mining for Information Retrieval: Methodologies, Techniques and Applications (2021): 163-195. |
|
Park, Ji Jeong, Keun-joo Yoo, Min Lee, Jooyeon Park, Eunjung Park, Ji Yun Tark, Sungkyu Lee, and Chaemin Shin. "Research & Reviews: Journal of Medical and Health Sciences." |
|
Solayman, Yahya Farahat Solayman. "Combination of platinums and phytochemicals aimed to overcome drug resistance in cancer." PhD diss., University of Sydney, 2020. |
|
Lu, D. Y., and J. Y. Che. "Personalized Medicine for Obese Treatments." Int. J. Biopro. Biotechnol. Advance 5, no. 1 (2019): 177-179. |
|
Lu, Da-Yong, and Ting-Ren Lu. "Drug sensitivity testing, a unique drug selection strategy." Advances in Biomarker Sciences and Technology (2020). |
|
Yazdani, Hossein, Leo L. Cheng, David C. Christiani, and Azam Yazdani. "Bounded Fuzzy Possibilistic Method reveals information about lung cancer through analysis of metabolomics." IEEE/ACM transactions on computational biology and bioinformatics 17, no. 2 (2018): 526-535. |
|
Lu, D. Y., T. R. Lu, B. Xu, J. Ding, and N. S. Yarla. "Clinical cancer therapy, personalized chemotherapies." J Cell Dev Biol 1, no. 1 (2017): 5. |
|
Lu, Da-Yong, Ting-Ren Lu, En-Hong Chen, Nagendra Sastry Yarla, Bin Xu, Jian Ding, Min Huang, and Hong Zhu. "Keep up the pace of drug development evolution and expenditure." Cancer Rep Rev 2, no. 5 (2018): 165. |
|
Lu, Da-Yong, Rong-Xin Qu, Ting-Ren Lu, and Hong-Ying Wu. "Cancer bioinformatics for updating anticancer drug developments and personalized therapeutics." Reviews on recent clinical trials 12, no. 2 (2017): 101-110. |
|
Lu, Da-Yong, Ting-Ren Lu, Bin Xu, Jin-Yu Che, Ying Shen, and Nagendra S. Yarla. "Individualized cancer therapy, future approaches." Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics) 16, no. 2 (2018): 156-163. |
|
Altay, Ahmet. "Synthesis of Quinazoline-based Chiral Thioureas and Their Anti-Cancer Potentials on Breast and Colon Cancer Cell Lines." |
|
Da-Yong, L., and L. Ting-Ren. "Anticancer drug development, challenge and dilemma." Nurse Care Open Acces J 7, no. 3 (2020): 72-75. |
|
Lu, Da-Yong, Ting-Ren Lu, Bin Xu, Ajit Varki, Min Huang, Hong Zhu, Ying Shen, and Nagendra Sastry Yarla. "Aberrant Sialylation in Cancer Pathology and Metastasis, a Putative Drug Target Candidate." Anti-cancer agents in medicinal chemistry 18, no. 14 (2018): 1952-1961. |
|
Lu, Da-Yong, Ting-Ren Lu, Nagendra Sastry Yarla, Yi Lu, Jin-Yu Che, Jian Ding, Bin Xu, Hong Zhu, Ying Shen, and Hong-Ying Wu. "Natural drug cancer treatments, strategies from herbal medicine to chemical or biological drugs." In Studies in Natural Products Chemistry, vol. 66, pp. 91-115. Elsevier, 2020. |
|
Lu, Da-Yong, and Ting-Ren Lu. "Drug discoveries from natural resources." of 8 (2019): 8-11. |
|
Giri, Tapan Kumar, and Bijaya Ghosh, eds. Polysaccharide Based Nano-biocarrier in Drug Delivery. CRC Press, 2018. |
|
Lu, Da-Yong, Ting-Ren Lu, En-Hong Chen, Nagendra Sastry Yarla, Bin Xu, Jian Ding, Min Huang, and Hong Zhu. "Keep up the pace of drug development evolution and expenditure." Cancer Rep Rev 2, no. 5 (2018): 165. |
|
Lu, D. Y., T. R. Lu, X. L. Chen, B. Xu, and J. Ding. "Plasma Fibrinogen Concentrations in Patients with Solid Tumors and Therapeutic Improvements by Combining Anticoagulants or Fibrinolytical Agents." Adv Pharmacoepidemiol Drug Saf 4 (2015): e133. |
|
Lu, Da-Yong, Rong-Xin Qu, Ting-Ren Lu, and Hong-Ying Wu. "Cancer bioinformatics for updating anticancer drug developments and personalized therapeutics." Reviews on recent clinical trials 12, no. 2 (2017): 101-110. |
|
Lu, Da-Yong, Ting-Ren Lu, En-Hong Chen, B. Xu, N. S. Yarla, H. Zhu, and J. Ding. "Anticancer drug development, system updating and global participations." Current Drug Therapy 12, no. 1 (2017): 37-45. |
|
Metabolomics:Open Access received 895 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 